Department of Renal Medicine, Barts Health NHS Trust, London, UK.
Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Nat Rev Nephrol. 2021 Apr;17(4):225-226. doi: 10.1038/s41581-020-00379-y.
A new study reports the seroprevalence of SARS-CoV-2 antibodies among a cross-section of patients on haemodialysis and uses these data to estimate seroprevalence in the general US population. Although this study demonstrates the potential of monitoring infectious disease prevalence in dialysis populations, the findings should be interpreted with caution.
一项新的研究报告了血液透析患者中 SARS-CoV-2 抗体的血清阳性率，并利用这些数据来估计美国普通人群中的血清阳性率。尽管这项研究表明了在透析人群中监测传染病流行情况的潜力，但研究结果应谨慎解释。
